MeiraGTx Holdings PLC - ESG Rating & Company Profile powered by AI
The page contains a free E,S&G analysis for MeiraGTx Holdings PLC. Detailed ESG analysis of MeiraGTx Holdings PLC are reached by logging in. If you are employed by MeiraGTx Holdings PLC and you wish to licence your ESG aseessment, please contact us.
MeiraGTx Holdings PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 3.2 and governance score of 3.2.
2.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | MeiraGTx Holdings PLC | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does MeiraGTx Holdings PLC have an accelerator or VC vehicle to help deliver innovation?
Does MeiraGTx Holdings PLC disclose current and historical energy intensity?
Does MeiraGTx Holdings PLC report the average age of the workforce?
Does MeiraGTx Holdings PLC reference operational or capital allocation in relation to climate change?
Does MeiraGTx Holdings PLC disclose its ethnicity pay gap?
Does MeiraGTx Holdings PLC disclose cybersecurity risks?
Does MeiraGTx Holdings PLC offer flexible work?
Does MeiraGTx Holdings PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does MeiraGTx Holdings PLC disclose the number of employees in R&D functions?
Does MeiraGTx Holdings PLC conduct supply chain audits?
Does MeiraGTx Holdings PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does MeiraGTx Holdings PLC conduct 360 degree staff reviews?
Does MeiraGTx Holdings PLC disclose the individual responsible for D&I?
Does MeiraGTx Holdings PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does MeiraGTx Holdings PLC disclose current and / or historical scope 2 emissions?
Does MeiraGTx Holdings PLC disclose water use targets?
Does MeiraGTx Holdings PLC have careers partnerships with academic institutions?
Did MeiraGTx Holdings PLC have a product recall in the last two years?
Does MeiraGTx Holdings PLC disclose incidents of discrimination?
Does MeiraGTx Holdings PLC allow for Work Councils/Collective Agreements to be formed?
Has MeiraGTx Holdings PLC issued a profit warning in the past 24 months?
Does MeiraGTx Holdings PLC disclose parental leave metrics?
Does MeiraGTx Holdings PLC disclose climate scenario or pathway analysis?
Does MeiraGTx Holdings PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does MeiraGTx Holdings PLC disclose the pay ratio of women to men?
Does MeiraGTx Holdings PLC support suppliers with sustainability related research and development?
Does MeiraGTx Holdings PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does MeiraGTx Holdings PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is MeiraGTx Holdings PLC involved in embryonic stem cell research?
Does MeiraGTx Holdings PLC disclose GHG and Air Emissions intensity?
Does MeiraGTx Holdings PLC disclose its waste policy?
Does MeiraGTx Holdings PLC report according to TCFD requirements?
Does MeiraGTx Holdings PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does MeiraGTx Holdings PLC disclose energy use targets?
Does MeiraGTx Holdings PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does MeiraGTx Holdings PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for MeiraGTx Holdings PLC
These potential risks are based on the size, segment and geographies of the company.
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.